Immuron Limited (NASDAQ: IMRN)

Published August 20, 2026

Views 3.12K | Likes 37 | Comments 0

Views#1,840,035

Views#345,769

Channel

Emerging Growth Conference

Emerging Growth Conference

14.3K subs•1.37K videos•Feb 2021

Views

3,124

Likes

37

Comments

0

Performance vs. channel

Outlier score

Engagement rate

Revenue estimate

Total (all-time): $2 – $6

Based on estimated $0.7–$2 CPM.

More features coming

We're working on new analytics and tools. Stay tuned.

About

Immuron Limited (NASDAQ: IMRN), is a biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatment of infectious diseases. Keynote speaker: Steve Lydeamore, CEO

Published: August 20, 2026
Made for kids: No

More features coming

We're working on new analytics and tools. Stay tuned.